|
JP6806562B2
(ja)
|
2013-03-15 |
2021-01-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ｅＩＦ２α経路の調節因子
|
|
TWI763668B
(zh)
|
2016-05-05 |
2022-05-11 |
美商嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TW201808903A
(zh)
*
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TW201808888A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TW201808914A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
AU2017279027A1
(en)
|
2016-06-08 |
2018-12-20 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical Compounds
|
|
CA3026982A1
(en)
|
2016-06-08 |
2017-12-14 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds as atf4 pathway inhibitors
|
|
WO2018225093A1
(en)
|
2017-06-07 |
2018-12-13 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds as atf4 pathway inhibitors
|
|
US20210145771A1
(en)
|
2017-07-03 |
2021-05-20 |
Glaxosmithkline Intellectual Property Development Limited |
N-(3-(2-(4-chlorophenoxy)acetamido)bicyclo[1.1.1] pentan-1-yl)-2-cyclobutane-1- carboxamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases
|
|
CN110896634A
(zh)
|
2017-07-03 |
2020-03-20 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为atf4抑制剂用于治疗癌症和其它疾病的2-(4-氯苯氧基)-n-((1-(2-(4-氯苯氧基)乙炔氮杂环丁烷-3-基)甲基)乙酰胺衍生物和相关化合物
|
|
CN118239937A
(zh)
|
2017-08-09 |
2024-06-25 |
戴纳立制药公司 |
化合物、组合物及方法
|
|
DK3676297T3
(da)
|
2017-09-01 |
2023-08-14 |
Denali Therapeutics Inc |
Forbindelser, sammensætninger og fremgangsmåder
|
|
UY37957A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
US11939320B2
(en)
*
|
2017-11-02 |
2024-03-26 |
Abbvie Inc. |
Modulators of the integrated stress pathway
|
|
CA3080804A1
(en)
|
2017-11-02 |
2019-05-09 |
Calico Life Sciences Llc |
Modulators of the integrated stress pathway
|
|
UY37956A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
EP3704098B1
(en)
|
2017-11-02 |
2024-01-24 |
Calico Life Sciences LLC |
Modulators of the integrated stress pathway
|
|
UY37958A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
EP3704125B1
(en)
*
|
2017-11-02 |
2026-03-11 |
Calico Life Sciences LLC |
Modulators of the integrated stress pathway
|
|
SG11202004009TA
(en)
|
2017-11-02 |
2020-05-28 |
Calico Life Sciences Llc |
Modulators of the integrated stress pathway
|
|
EP3704096B1
(en)
|
2017-11-02 |
2026-04-22 |
Calico Life Sciences LLC |
Modulators of the integrated stress pathway
|
|
WO2019118785A2
(en)
|
2017-12-13 |
2019-06-20 |
Praxis Biotech LLC |
Inhibitors of integrated stress response pathway
|
|
WO2019183589A1
(en)
|
2018-03-23 |
2019-09-26 |
Denali Therapeutics Inc. |
Modulators of eukaryotic initiation factor 2
|
|
WO2019193540A1
(en)
|
2018-04-06 |
2019-10-10 |
Glaxosmithkline Intellectual Property Development Limited |
Heteroaryl derivatives of formula (i) as atf4 inhibitors
|
|
WO2019193541A1
(en)
|
2018-04-06 |
2019-10-10 |
Glaxosmithkline Intellectual Property Development Limited |
Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors
|
|
WO2019236710A1
(en)
*
|
2018-06-05 |
2019-12-12 |
Praxis Biotech LLC |
Inhibitors of integrated stress response pathway
|
|
JP2021529814A
(ja)
|
2018-07-09 |
2021-11-04 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
化学化合物
|
|
WO2020031107A1
(en)
|
2018-08-08 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
|
TWI877863B
(zh)
|
2018-10-11 |
2025-03-21 |
美商嘉來克生命科學有限責任公司 |
整合應激路徑之前藥調節劑
|
|
MA54953A
(fr)
|
2019-02-13 |
2021-12-22 |
Denali Therapeutics Inc |
Composés, compositions et procédés
|
|
US12091392B2
(en)
|
2019-02-13 |
2024-09-17 |
Denali Therapeutics Inc. |
Compounds, compositions and methods
|
|
US20200270232A1
(en)
|
2019-02-25 |
2020-08-27 |
Praxis Biotech LLC |
Inhibitors of integrated stress response pathway
|
|
US20220177456A1
(en)
|
2019-03-06 |
2022-06-09 |
Denali Therapeutics Inc. |
Compounds, compositions and methods
|
|
MX2021012904A
(es)
|
2019-04-23 |
2022-01-18 |
Evotec Int Gmbh |
Moduladores de la via de respuesta al estres integrada.
|
|
CA3137213A1
(en)
|
2019-04-23 |
2020-10-29 |
Evotec International Gmbh |
Modulators of the integrated stress response pathway
|
|
AR118836A1
(es)
|
2019-04-30 |
2021-11-03 |
Calico Life Sciences Llc |
Moduladores de la vía de tensión integrada
|
|
MX2021013197A
(es)
*
|
2019-04-30 |
2022-02-24 |
Calico Life Sciences Llc |
Cicloalquilos sustituidos como moduladores de la vía integrada del estrés.
|
|
MX2021015210A
(es)
|
2019-06-12 |
2022-01-18 |
Praxis Biotech LLC |
Inhibidores de la via de respuesta al estres integrada.
|
|
JP2022536663A
(ja)
|
2019-06-12 |
2022-08-18 |
プラクシス バイオテック エルエルシー |
統合的ストレス応答経路のモジュレーター
|
|
AU2021213289A1
(en)
|
2020-01-28 |
2022-07-07 |
Evotec International Gmbh |
Modulators of the integrated stress response pathway
|
|
MX2022011143A
(es)
|
2020-03-11 |
2022-10-13 |
Evotec Int Gmbh |
Moduladores de la via de respuesta integrada al estres.
|